Network and cellular vulnerability to pathological protein progression
网络和细胞对病理性蛋白质进展的脆弱性
基本信息
- 批准号:10614031
- 负责人:
- 金额:$ 44.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAnatomyAnimal ModelAtlasesBehavior assessmentBindingBrainBrain PathologyBrain regionCellsClinicalComplexComputer ModelsDataDementiaDementia with Lewy BodiesDevelopmentDiffusionDiseaseDisease ProgressionEvaluationGene ExpressionHippocampusHumanImmunofluorescence ImmunologicIn Situ HybridizationIndividualInjectionsKnock-in MouseLewy Body DiseaseMapsMissionModelingMolecularMolecular ProfilingMusNatureNerve DegenerationNeuritesNeuroanatomyNeurodegenerative DisordersNeuronsPathogenicityPathologicPathologyPathway AnalysisPatientsPersonsPhysiologyPopulationProteinsResearchResolutionResourcesSenile PlaquesTestingTimeTreatment EfficacyUnited StatesUnited States National Institutes of HealthWild Type MouseWorkalpha synucleinbeta amyloid pathologycerebral atrophyconnectomedisease prognosisefficacy evaluationextracellularhuman modelimprovedinsightmolecular markernetwork modelsnovelnovel therapeutic interventionphosphoneuroprotein 14protein aggregationresiliencespatiotemporaltau Proteinstau aggregationtau mutationtooltranscriptomics
项目摘要
PROJECT SUMMARY/ABSTRACT
Over 6.5 million people in the United States currently live with progressive neurodegenerative Alzheimer’s
disease (AD) and related dementias including dementia with Lewy bodies (DLB), yet no treatments to stop their
progression are available. The presence of aggregated proteins in the brain (tau, amyloid β (Aβ), and α-
synuclein) is thought to underlie disease, and clinical overlap in presentation of these diseases associates with
the presence of more than one type of pathology. The factors influencing cellular and network vulnerability to
each individual pathology or co-occurring pathologies are not well-understood. A proper understanding of
vulnerability in the context of co-pathologies is necessary for the development and evaluation of novel disease-
modifying treatments.
This project will test the hypothesis that progression of intracellular α-synuclein and tau pathologies are bound
by neuroanatomical connectivity but influenced by network and cell-level vulnerability. Network and cell-level
vulnerability may also be influenced by additional factors such as the presence of co-pathologies, including
extracellular amyloid β (Aβ) plaques. To test this hypothesis, the following aims will be pursued: (i) progression
of α-synuclein and tau pathologies will be mapped in wildtype mice bearing single or multiple pathologies at high
resolution using registration to a common neuroanatomical atlas, and network parameters of progression will be
assessed with computational modeling (Specific Aim 1); quantitative pathology and network analysis will be
utilized to assess the impact of Aβ plaques on the development, spread, and network vulnerability to α-synuclein
and tau co-pathology in knock-in mice that express human tau and develop Aβ plaques and in a time-dependent
manner (Specific Aim 2); spatial transcriptomics of human AD brain, DLB brain, and mouse co-pathology brain
will be used to determine unique molecular signatures of neurons vulnerable to α-synuclein or tau pathologies.
Vulnerability signatures will be validated with combined in situ hybridization-immunofluorescence and integrated
with network vulnerability and regional gene expression to develop and evaluate a model of human co-pathology
progression as a resource for understanding disease progression and evaluating therapeutic efficacy (Specific
Aim 3).
The proposed research is expected to improve our understanding of the spatiotemporal progression of co-
pathologies and to develop improved tools to evaluate efficacy of novel therapeutic strategies that could slow
the progression of neurodegenerative diseases.
项目总结/摘要
美国目前有超过650万人患有进行性神经退行性阿尔茨海默病
疾病(AD)和相关痴呆,包括路易体痴呆(DLB),但没有治疗方法来阻止他们的行为。
进步是可用的。脑中聚集蛋白(tau蛋白、淀粉样蛋白β(Aβ)和α-淀粉样蛋白)的存在与脑中的蛋白质含量有关。
突触核蛋白)被认为是疾病的基础,这些疾病的临床重叠表现与
存在一种以上的病理类型。影响蜂窝和网络脆弱性的因素
每个单独的病理或共同发生的病理没有被很好地理解。正确了解
共同病理学背景下的脆弱性对于开发和评估新疾病是必要的-
修改治疗方法。
该项目将检验细胞内α-突触核蛋白和tau蛋白病理学的进展是结合在一起的假设
受神经解剖学连接的影响,但受网络和细胞水平脆弱性的影响。网络和单元级
脆弱性还可能受到其他因素的影响,如共同病理学的存在,包括
细胞外淀粉样β(Aβ)斑块。为了检验这一假设,将追求以下目标:
α-突触核蛋白和tau病理将在高浓度下携带单一或多种病理的野生型小鼠中进行定位。
将使用配准到常见神经解剖图谱的分辨率和进展的网络参数,
通过计算建模(具体目标1)进行评估;将进行定量病理学和网络分析。
用于评估Aβ斑块对α-突触核蛋白的发育、扩散和网络脆弱性的影响
在表达人tau蛋白并形成Aβ斑块的基因敲入小鼠中,
人AD脑、DLB脑和小鼠共病理脑的空间转录组学
将用于确定易受α-突触核蛋白或tau病理影响的神经元的独特分子特征。
脆弱性特征将通过结合原位杂交-免疫荧光和整合
利用网络脆弱性和区域基因表达来开发和评估人类共同病理学模型,
进展作为了解疾病进展和评估治疗疗效的资源(具体
目标3)。
这项研究有望提高我们对协同效应时空进程的理解,
并开发改进的工具来评估新的治疗策略的有效性,
神经退行性疾病的进展。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease.
- DOI:10.1038/s41531-023-00517-w
- 发表时间:2023-05-11
- 期刊:
- 影响因子:8.7
- 作者:Leyns, Cheryl E. G.;Prigent, Alice;Beezhold, Brenna;Yao, Lihang;Hatcher, Nathan G.;Tao, Peining;Kang, John;Suh, EunRan;Van Deerlin, Vivianna M.;Trojanowski, John Q.;Lee, Virginia M. Y.;Kennedy, Matthew E.;Fell, Matthew J.;Henderson, Michael X.
- 通讯作者:Henderson, Michael X.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Henderson其他文献
Michael Henderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Henderson', 18)}}的其他基金
Network and cellular vulnerability to pathological protein progression
网络和细胞对病理性蛋白质进展的脆弱性
- 批准号:
10446480 - 财政年份:2022
- 资助金额:
$ 44.28万 - 项目类别:
Investigating the role of MARKs in Parkinson's disease pathogenesis
研究 MARK 在帕金森病发病机制中的作用
- 批准号:
10214155 - 财政年份:2020
- 资助金额:
$ 44.28万 - 项目类别:
CSP alpha regulation of exo-endocytic cycle enhances synaptic stability
CSP α 外吞-内吞循环的调节增强突触稳定性
- 批准号:
8312242 - 财政年份:2012
- 资助金额:
$ 44.28万 - 项目类别:
CSP alpha regulation of exo-endocytic cycle enhances synaptic stability
CSP α 外吞-内吞循环的调节增强突触稳定性
- 批准号:
8450953 - 财政年份:2012
- 资助金额:
$ 44.28万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 44.28万 - 项目类别:
Grant-in-Aid for Scientific Research (B)